ES8505936A1 - Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico - Google Patents

Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico

Info

Publication number
ES8505936A1
ES8505936A1 ES534570A ES534570A ES8505936A1 ES 8505936 A1 ES8505936 A1 ES 8505936A1 ES 534570 A ES534570 A ES 534570A ES 534570 A ES534570 A ES 534570A ES 8505936 A1 ES8505936 A1 ES 8505936A1
Authority
ES
Spain
Prior art keywords
same
drug containing
polyprenyl compound
polyprenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534570A
Other languages
English (en)
Other versions
ES534570A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES8505936A1 publication Critical patent/ES8505936A1/es
Publication of ES534570A0 publication Critical patent/ES534570A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE AMIDAS DERIVADAS DE UN ACIDO POLIPRENILCARBOXILICO, DE FORMULA GENERAL (I), Y SUS SALES FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN HACER REACCIONAR UN HALURO DE UN COMPUESTO POLIPRENILICO DE FORMULA GENERAL (II), EN LA QUE HAL ES UN HALOGENO, CON UNA AMINA DE FORMULA GENERAL R22H.DE APLICACION EN LA PREPARACION DE COMPOSICIONES FARMACEUTICAS POR SU ACTIVIDAD ANTI-FAP Y ANTITROMBOSICA.
ES534570A 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico Granted ES534570A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57208678A JPS59101448A (ja) 1982-11-30 1982-11-30 ポリプレニルカルボン酸アミドおよびその製造方法ならびにそれを含有する医薬

Publications (2)

Publication Number Publication Date
ES8505936A1 true ES8505936A1 (es) 1985-06-16
ES534570A0 ES534570A0 (es) 1985-06-16

Family

ID=16560245

Family Applications (7)

Application Number Title Priority Date Filing Date
ES527634A Expired ES8600212A1 (es) 1982-11-30 1983-11-29 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico.
ES534569A Granted ES534569A0 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico
ES534570A Granted ES534570A0 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico
ES534566A Granted ES534566A0 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico
ES534571A Granted ES534571A0 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico
ES534568A Granted ES534568A0 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico
ES534567A Expired ES8507470A1 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES527634A Expired ES8600212A1 (es) 1982-11-30 1983-11-29 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico.
ES534569A Granted ES534569A0 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES534566A Granted ES534566A0 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico
ES534571A Granted ES534571A0 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico
ES534568A Granted ES534568A0 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico
ES534567A Expired ES8507470A1 (es) 1982-11-30 1984-07-23 Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico

Country Status (8)

Country Link
US (2) US4742058A (es)
EP (1) EP0110397B1 (es)
JP (1) JPS59101448A (es)
KR (1) KR860001879B1 (es)
CA (1) CA1204750A (es)
DE (1) DE3380062D1 (es)
ES (7) ES8600212A1 (es)
PH (1) PH20921A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791932A (en) * 1980-11-28 1982-06-08 Kuraray Co Ltd Polyprenyl compound
JPS60123451A (ja) * 1983-12-07 1985-07-02 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
CA1280414C (en) * 1985-03-15 1991-02-19 Saichi Matsumoto Isoprenoidamine derivatives and antiulcer agents
JPH0629218B2 (ja) * 1985-03-15 1994-04-20 エーザイ株式会社 ポリプレニル系化合物
US4917045A (en) * 1988-07-22 1990-04-17 Ethyl Corporation Silicon compounds in poultry hatching
JPH0418056A (ja) * 1990-05-09 1992-01-22 Sanwa Kagaku Kenkyusho Co Ltd ポリイソプレン化合物及びその塩、これ等の製法並びにこれ等を有効成分とする消化性潰瘍治療剤
WO1992003415A1 (en) * 1990-08-14 1992-03-05 Nova Pharmaceutical Corporation Protein kinase c modulators
US5189046A (en) * 1990-08-14 1993-02-23 Nova Pharmaceutical Corporation Protein kinase C modulators
US5574025A (en) * 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
WO2005021046A1 (en) * 2003-09-01 2005-03-10 Fh Faulding & Co Ltd Compositions and methods for delivery of biologically active agents
JP4886506B2 (ja) * 2004-02-25 2012-02-29 国立大学法人 東京大学 転写因子ｋｌｆ５の活性化抑制作用を有する医薬
IL187247A0 (en) 2007-11-08 2008-12-29 Hadasit Med Res Service Novel synthetic analogs of sphingolipids
CN103492358A (zh) * 2011-02-23 2014-01-01 埃克斯-马赛大学 聚氨基异戊(间)二烯衍生物在抗生素或杀菌剂治疗中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH122286A (de) * 1925-09-02 1927-09-01 Chem Ind Basel Verfahren zur Darstellung einer neuen Gallensäureverbindung.
US2649438A (en) * 1950-10-28 1953-08-18 Ind Rayon Corp Copolymers of acrylonitrile and basic acrylamides
US2595907A (en) * 1950-12-30 1952-05-06 American Cyanamid Co Polymerizable and polymerized acrylonitrile-dialkylaminopropylacrylamide compositions
US2760977A (en) * 1953-06-03 1956-08-28 Research Corp N-alkylol unsaturated amides
US3528987A (en) * 1964-07-31 1970-09-15 Geigy Chem Corp N-(substituted pyridyl)rinolamides and -linolenamides
CH514550A (de) * 1966-09-15 1971-10-31 Zoecon Corp Verfahren zur Herstellung neuer ungesättigter Carbonsäureamide
US4021224A (en) * 1971-12-09 1977-05-03 Stauffer Chemical Company Herbicide compositions
US4148926A (en) * 1977-10-04 1979-04-10 Stauffer Chemical Company Dialkyl amino ethyl amides as anti-ripening agents
US4456603A (en) * 1979-08-14 1984-06-26 Eisai Co., Ltd. Polyprenylcarboxylic acid amides useful for treating liver dysfunction
JPS56113718A (en) * 1980-01-12 1981-09-07 Agency Of Ind Science & Technol Bifunctional terpenoid, its preparation, and ulcer preventive agent comprising it
JPS5731615A (en) * 1980-07-31 1982-02-20 Eisai Co Ltd Remedy for skin disease with keratinization
JPS57192340A (en) * 1981-05-18 1982-11-26 Nisshin Flour Milling Co Ltd Isoprenylamine derivative

Also Published As

Publication number Publication date
ES527634A0 (es) 1985-10-01
CA1204750A (en) 1986-05-20
ES8506593A1 (es) 1985-08-01
PH20921A (en) 1987-06-05
JPS59101448A (ja) 1984-06-12
EP0110397A3 (en) 1985-01-23
JPH0330585B2 (es) 1991-04-30
ES534570A0 (es) 1985-06-16
ES534567A0 (es) 1985-09-01
ES8506261A1 (es) 1985-07-01
KR840006803A (ko) 1984-12-03
ES8600212A1 (es) 1985-10-01
ES534566A0 (es) 1985-08-01
US4742058A (en) 1988-05-03
US4762829A (en) 1988-08-09
ES8506262A1 (es) 1985-07-01
DE3380062D1 (en) 1989-07-20
EP0110397A2 (en) 1984-06-13
KR860001879B1 (ko) 1986-10-24
ES534569A0 (es) 1985-07-01
EP0110397B1 (en) 1989-06-14
ES8601104A1 (es) 1985-10-16
ES534571A0 (es) 1985-07-01
ES534568A0 (es) 1985-10-16
ES8507470A1 (es) 1985-09-01

Similar Documents

Publication Publication Date Title
AU8835682A (en) D-amino acid amides
AU567148B2 (en) Metal containing active carbon
AU578837B2 (en) 7 (Substituted) amino -8- Substituted (carbonyl)- methylamino -1-oxaspiro 4.5 decanes as analgesic agents
ES8507470A1 (es) Un procedimiento para la preparacion de nuevas amidas de un acido poliprenilcarboxilico
ES8705758A1 (es) Metodo de preparacion de tabletas por compresion directa.
AU543307B2 (en) Imidazoazole-alkenoic acid amide compounds
AU8757782A (en) Field emission electrodes
GB2046745B (en) Farnesylacetic acid amide compound
AU537402B2 (en) 3,7,11,15-tetra methyl-2-4,6,10,14-hexadecapenta enoic acid
JPS5524179A (en) 1*2*33triazole carboxylic acid amide*its manufacture and antibacterial containing it
JPS56169660A (en) Manufacture of carboxylic acid amide
AU8135782A (en) Phosphoric nphosphonic acid ester amides
JPS57122068A (en) N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same
JPS5632441A (en) Carboxylic acid amide
IL71513A0 (en) Polycyclic carboxylic acid compounds,processes for the manufacture thereof and preparations containing such carboxylic acid compounds,and the use thereof
GB2078724B (en) Carboxylic acid amides
AU582117B2 (en) Carboxylic acid amide compounds and their derivatives
JPS57159792A (en) Phosphoric acid ester amides, manufacture and use
IL71989A (en) L-arginine isoxicamate and pharmaceutical compositions containing it
SU1167881A1 (ru) Фенилгидразид морфолинодиэтилуксусной кислоты, обладающий противотуберкулезным действием
JPS56131545A (en) Ester of arylpropionic acid, its manufacture and medicine of its effective component
SU1198912A1 (ru) Арилгидразиды 2-бутилгекс-2-еновой кислоты, проявляющие противотуберкулезную активность, и способ их получения
JPS56122341A (en) Substituted naphthoic acids* manufacture and use as drug
JPS535138A (en) Carbanilic acid ester* process for manufacture thereof and herbicide containing said compound
JPS56145289A (en) Manufacture of 5-formyl-5,6,7,8-tetrahydrofolic acid